Dr. Edmund Folefac, in an NPR interview yesterday, discusses the value of a screening prostate specific antigen (PSA) test, the most commonly used screening test for prostate cancer. In this short interview lasting about 15-20 minutes, Dr. Folefac answered questions from listeners about recent advances in the management of prostate cancer, whose incidence has been rising in recent years. Other than non-melanoma skin cancer, prostate cancer is the most common cancer among men in the United States. All men are at risk for prostate cancer. The most common risk factors are age, back race, and a family history of prostate cancer. If you are concerned that you may be at greater risk for prostate cancer, listen to this interview, then talk to your doctor about prostate cancer screening, especially since recent changes in the screening guidelines may benefit black people like us.
Dr. Edmund Folefac’s NPR interview on prostate cancer.